This test is most useful if any of these apply to you.
If you have unexplained vaginal burning, yellow or yellow-green discharge, or recurring irritation that keeps coming back after standard treatment, aerobic vaginitis (AV) may be the answer your routine swab missed. It is a distinct, inflammation-driven condition that is often confused with bacterial vaginosis but behaves very differently in your body.
Unlike many common vaginal panels that look only for bacterial vaginosis, Candida, and Trichomonas, this test specifically detects the aerobic bacterial overgrowth pattern that drives AV. Knowing whether AV is present changes which treatment will actually work and which can make things worse.
AV (aerobic vaginitis) is not a single molecule but a composite pattern seen on a vaginal swab. It combines four observations: a drop in protective Lactobacillus bacteria, the appearance of oxygen-loving bacteria like Escherichia coli, Klebsiella, Enterococcus, group B Streptococcus, and Staphylococcus aureus, the presence of inflammatory white blood cells, and the appearance of immature surface cells called parabasal cells.
The reference diagnostic method uses a scoring system (the Donders score) on a vaginal smear, where higher scores indicate more severe AV. Many modern labs also use molecular methods (quantitative PCR, a DNA-based bacterial counting technique) to identify the specific aerobic bacteria involved and confirm reduced lactobacilli.
In a study of 323 Vietnamese pregnant women, AV in the third trimester was about 8.6 times more likely to be followed by puerperal sepsis (serious infection after delivery) compared to women without AV (odds ratio 8.65, with a wide confidence interval reflecting the small number of events). AV was found in 15.5% of these pregnant women, making it far from rare.
A larger study of 624 women in late pregnancy (part of a broader 989-person cohort that also included nonpregnant controls) found AV was common and associated with premature rupture of membranes. Narrative reviews link AV during pregnancy to premature delivery, stillbirth, and other adverse outcomes, though the exact mechanisms continue to be studied.
In a study of 622 women, moderate or severe AV and vaginal inflammation were independently associated with an increased risk of major cervical cell abnormalities found on Pap smears. Bacterial vaginosis, by contrast, was not. This is an important distinction because it pushes back on the common assumption that any vaginal dysbiosis carries the same cervical risk.
This isn't a paradox so much as a reminder that vaginal infections are not interchangeable. AV is driven by inflammation and tissue irritation, while bacterial vaginosis is largely non-inflammatory. The inflammation associated with AV appears to be what creates the cellular environment linked with abnormal cervical findings.
AV is frequently found in mixed infections alongside bacterial vaginosis and vulvovaginal candidiasis. In a study of 1,674 women, mixed vaginitis in late pregnancy was associated with increased risk of peripartum infection. In fertility settings, broad vaginal dysbiosis (including AV) has been linked to higher early pregnancy loss in women undergoing IVF, though the evidence is not AV-specific.
AV is also notable for antibiotic resistance. In an Ethiopian study of reproductive-age women, roughly 66% of the bacteria causing AV were multidrug-resistant. An Italian retrospective study of 2,069 women found that aerobic vaginitis pathogens showed substantial resistance to penicillins and tetracyclines. This means treating blindly without identifying the specific bacteria can fail.
| Feature | Aerobic Vaginitis | Bacterial Vaginosis |
|---|---|---|
| Inflammation | Pronounced, with white blood cells | Minimal to none |
| Typical bacteria | E. coli, Strep, Staph, Enterococcus | Gardnerella, Prevotella, Atopobium |
| Discharge | Yellow to green, thick or mucoid, foul or rotten odor in severe cases | Thin, gray-white, fishy odor |
| Cervical cell abnormality risk | Increased (moderate or severe AV) | Not independently associated |
| Detected on standard BV panel | Often no | Yes |
What this means for you: a negative bacterial vaginosis test does not rule out AV. In one molecular study, women classified as having 'altered flora' on standard BV scoring sometimes tested AV-positive when checked with a specific AV-focused method. If your symptoms persist after BV treatment, AV is a leading possibility worth investigating directly.
The vaginal microbiome shifts substantially across the menstrual cycle, with sexual activity, after antibiotic use, and during pregnancy. A single swab gives you a snapshot, not a trajectory. If your first test shows AV, a follow-up test 3 to 4 weeks after treatment is the most reliable way to confirm the infection actually cleared, since symptom improvement does not always equal microbiological cure.
In an RCT of 80 women with mixed AV and bacterial vaginosis, total bacterial counts dropped sharply right after treatment and rebounded slightly weeks later. Tracking your trend across baseline, post-treatment, and recurrence checkpoints gives you a much clearer picture than a one-time result. For anyone experiencing recurrent symptoms, retesting every 3 to 6 months until consistently normal is reasonable.
If your result shows moderate or severe AV, the next step is not just retesting. Pair the swab with culture or molecular identification of the specific bacteria present, since AV pathogens are often multidrug-resistant. This identifies which treatment will actually work for your particular case. If you are pregnant, share the result with your obstetric team promptly given the link with premature rupture of membranes and postpartum infection.
If you are getting recurrent or mixed infections, request testing for bacterial vaginosis, Candida species, and Trichomonas alongside AV, because mixed infections are common and one negative test does not exclude the others. Consider a gynecologist or sexual health specialist familiar with AV if your local provider treats every case as bacterial vaginosis by default.
Evidence-backed interventions that affect your Aerobic Vaginitis level
Aerobic Vaginitis is best interpreted alongside these tests.
Aerobic Vaginitis is included in these pre-built panels.